Page last updated: 2024-08-16

scriptaid and decitabine

scriptaid has been researched along with decitabine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Davidson, NE; Keen, JC; Mack, KM; Pettit, C; Sharma, D; Smith, D; Yan, L	1
Kim, DH; Kim, SJ; Lee, BB; Lee, EJ; Park, J; Park, YD	1
Biancardi, MN; Dumas, C; Earle Pope, C; Galiguis, J; Gómez, MC; Jenkins, JA; Wang, G	1

Trials

1 trial(s) available for scriptaid and decitabine

Article	Year
Scriptaid and 5-aza-2'deoxycytidine enhanced expression of pluripotent genes and in vitro developmental competence in interspecies black-footed cat cloned embryos. Reproduction in domestic animals = Zuchthygiene, 2012, Volume: 47 Suppl 6 Topics: Animals; Azacitidine; Cats; Cloning, Organism; Decitabine; Embryo Transfer; Epigenesis, Genetic; Felis; Gene Expression Regulation, Developmental; Hydroxylamines; Quinolines	2012

Article

Year

Scriptaid and 5-aza-2'deoxycytidine enhanced expression of pluripotent genes and in vitro developmental competence in interspecies black-footed cat cloned embryos.

Reproduction in domestic animals = Zuchthygiene, 2012, Volume: 47 Suppl 6

Topics: Animals; Azacitidine; Cats; Cloning, Organism; Decitabine; Embryo Transfer; Epigenesis, Genetic; Felis; Gene Expression Regulation, Developmental; Hydroxylamines; Quinolines

2012

Other Studies

2 other study(ies) available for scriptaid and decitabine

Article	Year
A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine. Breast cancer research and treatment, 2003, Volume: 81, Issue:3 Topics: Acetylation; Antimetabolites, Antineoplastic; Azacitidine; Breast Neoplasms; Cell Division; Decitabine; DNA Modification Methylases; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Estrogen Receptor alpha; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxylamines; Inhibitory Concentration 50; Quinolines; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tumor Cells, Cultured	2003
Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells. International journal of oncology, 2008, Volume: 33, Issue:4 Topics: Apoptosis; Azacitidine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Decitabine; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genes, p16; Histone Deacetylase Inhibitors; Humans; Hydroxylamines; Promoter Regions, Genetic; Quinolines	2008

Article

Year

A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.

Breast cancer research and treatment, 2003, Volume: 81, Issue:3

Topics: Acetylation; Antimetabolites, Antineoplastic; Azacitidine; Breast Neoplasms; Cell Division; Decitabine; DNA Modification Methylases; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Estrogen Receptor alpha; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxylamines; Inhibitory Concentration 50; Quinolines; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tumor Cells, Cultured

2003

Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells.

International journal of oncology, 2008, Volume: 33, Issue:4

Topics: Apoptosis; Azacitidine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Decitabine; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genes, p16; Histone Deacetylase Inhibitors; Humans; Hydroxylamines; Promoter Regions, Genetic; Quinolines

2008